Skip to Content

Mayzent 0.25 mg film-coated tablets

Licence status
Authorised: 13/01/2020
Active substances
Siponomid, SIPONIMOD FUMARIC ACID
Dosage Form
Film-coated tablet
Licence number
EU/1/19/1414/001-002
Licence holder
Novartis Europharm Limited

Licence information

ATC code
L04AA42 siponimod
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
13/01/2020